Ad
BIOS - BioPlus Acquisition Stock Trading
About | BioPlus Acquisition Corp. (NASDAQ:BIOS)
Not available
Quote | BioPlus Acquisition Corp. (NASDAQ:BIOS)
| Last: | $10.83 |
|---|---|
| Change Percent: | 0.09% |
| Open: | $10.83 |
| Close: | $10.83 |
| High: | $10.83 |
| Low: | $10.83 |
| Volume: | 327 |
| Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | BioPlus Acquisition Corp. (NASDAQ:BIOS)
-
The Avertix Guardian™ System, the first and only FDA approved implantable heart attack warning system, now available at the Heart & Rhythm Institute of Trinity, extending their commitment to redefining cardiac care in the Tampa, FL area Dr. Luis R. Annoni-Suau, MD, FACC and D...
-
Recently served as Boston Scientific Executive Vice President and Global Chief Medical Officer Professor Meredith brings to Avertix over 35 years of cardiology experience and commitment to advancing cardiac care EATONTOWN, N.J., July 17, 2023 (GLOBE NEWSWIRE) -- Avertix Medi...
Message Board Posts | BioPlus Acquisition Corp. (NASDAQ:BIOS)
| Subject | By | Source | When |
|---|---|---|---|
| * * $BIOS Video Chart 09-18-2019 * * | ClayTrader | investorshub | 09/18/2019 9:49:58 PM |
| whytestocks: $BIOS News Article - Option Care and BioScrip Complete Merger to Form Option Care Healt | whytestocks | investorshangout | 08/07/2019 6:10:39 PM |
| whytestocks: $BIOS News Article - BioScrip Reports Second Quarter 2019 Financial Results | whytestocks | investorshangout | 07/30/2019 5:35:40 PM |
| $BIOS under accumulation | Wildbilly | investorshub | 07/16/2019 3:36:08 PM |
| * * $BIOS Video Chart 04-23-2019 * * | ClayTrader | investorshub | 04/23/2019 10:08:03 PM |
BioPlus Acquisition Corp. Company Name:
BIOS Stock Symbol:
NASDAQ Market:
BioPlus Acquisition Corp. Website:
Ad
-
Bioservo signs a Sales Agent agreement with Trivet Medical LLC for sales of Carbonhand to Hospitals, Clinics, and Medical Centers within the Vetera...
-
The Avertix Guardian™ System, the first and only FDA approved implantable heart attack warning system, now available at the Heart & Rhythm Institute of Trinity, extending their commitment to redefining cardiac care in the Tampa, FL area Dr. Luis R. Annoni-Suau, MD, FACC and D...
-
Recently served as Boston Scientific Executive Vice President and Global Chief Medical Officer Professor Meredith brings to Avertix over 35 years of cardiology experience and commitment to advancing cardiac care EATONTOWN, N.J., July 17, 2023 (GLOBE NEWSWIRE) -- Avertix Medi...